User profiles for Edward A. Neuwelt
 | edward neuweltneurosurgery and neurology professor oregon health sciences university Verified email at ohsu.edu Cited by 29443 |
[PDF][PDF] Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma
…, A Korfel, C Soussain, LM DeAngelis, EA Neuwelt… - J Clin …, 2005 - researchgate.net
Standardized guidelines for the baseline evaluation and response assessment of primary
CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly …
CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly …
Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means
RA Kroll, EA Neuwelt - Neurosurgery, 1998 - journals.lww.com
OBJECTIVE: This article reviews historical aspects of the blood-brain barrier (BBB) and recent
advances in mechanisms to deliver therapeutic agents across the BBB for the treatment of …
advances in mechanisms to deliver therapeutic agents across the BBB for the treatment of …
Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.
…, D Garwood, E Glatstein, EA Neuwelt - Journal of Clinical …, 1994 - ascopubs.org
PURPOSE To examine behavioral dimensions of treatment outcomes for patients receiving
cranial irradiation. Radiation encephalopathy is one of these and refers to significant …
cranial irradiation. Radiation encephalopathy is one of these and refers to significant …
Engaging neuroscience to advance translational research in brain barrier biology
The delivery of many potentially therapeutic and diagnostic compounds to specific areas of
the brain is restricted by brain barriers, of which the most well known are the blood–brain …
the brain is restricted by brain barriers, of which the most well known are the blood–brain …
[PDF][PDF] Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development
…, DF Kraemer, EA Neuwelt - Journal of Clinical …, 2005 - fennecpharma.com
… Research is needed to identify long-term educational and social outcomes in pediatric
patients treated with platinum-based chemotherapy. Several agents have been studied for …
patients treated with platinum-based chemotherapy. Several agents have been studied for …
Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous …
…, LL Muldoon, EA Neuwelt - Journal of Cerebral …, 2010 - journals.sagepub.com
Superparamagnetic iron oxide nanoparticles have diverse diagnostic and potential
therapeutic applications in the central nervous system (CNS). They are useful as magnetic …
therapeutic applications in the central nervous system (CNS). They are useful as magnetic …
Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients …
…, D Fortin, R Nixon, LL Muldoon, EA Neuwelt - Cancer, 2000 - Wiley Online Library
BACKGROUND The aim of this study was to determine the safety and efficacy of intraarterial
chemotherapy with osmotic opening of the blood‐brain barrier (BBB) for the treatment of …
chemotherapy with osmotic opening of the blood‐brain barrier (BBB) for the treatment of …
Long-circulating iron oxides for MR imaging
A variety of iron oxide preparations with long blood half-lives have been synthesized for MR
imaging. Potential applications of these agents include MR angiography, RES imaging, …
imaging. Potential applications of these agents include MR angiography, RES imaging, …
[PDF][PDF] Chemotherapy delivery issues in central nervous system malignancy: a reality check
…, DM Peereboom, EA Neuwelt - Journal of …, 2007 - oww-files-public.s3.amazonaws.com
… A study of rituximab immunotherapy in human PCNSL showed no uptake of IV 123I-rituximab
in brain50; however, clinical responses to rituximab in PCNSL have been reported.The long …
in brain50; however, clinical responses to rituximab in PCNSL have been reported.The long …
[HTML][HTML] Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric …
…, K Rajput, M Sullivan, EA Neuwelt - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Purpose The platinum chemotherapy agents cisplatin and carboplatin are widely used in
the treatment of adult and pediatric cancers. Cisplatin causes hearing loss in at least 60% of …
the treatment of adult and pediatric cancers. Cisplatin causes hearing loss in at least 60% of …